We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
3701
Fortuna Silver Mines
FSM
$3.17B
$121K ﹤0.01%
24,803
-39,682
-62% -$200K
AFB
3702
AllianceBernstein National Municipal Income Fund
AFB
$315M
$121K ﹤0.01%
10,894
-7,142
-40% -$76.9K
MFIN icon
3703
Medallion Financial
MFIN
$254M
$121K ﹤0.01%
15,725
IAF
3704
abrdn Australia Equity Fund
IAF
$128M
$121K ﹤0.01%
9,291
+901
+11% +$11.6K
EGIO
3705
DELISTED
Edgio, Inc. Common Stock
EGIO
$121K ﹤0.01%
11,044
-2,006
-15% -$21.2K
NUVO
3706
DELISTED
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NUVO
$120K ﹤0.01%
+100,000
New +$183K
ATEC icon
3707
Alphatec Holdings
ATEC
$1.47B
$119K ﹤0.01%
+11,353
New +$132K
UUU icon
3708
Universal Safety Products Inc
UUU
$10.5M
$118K ﹤0.01%
73,513
EPD icon
3709
PUT
Enterprise Products Partners
EPD
$82.2B
$115K ﹤0.01%
5,000
ALDX icon
3710
Aldeyra Therapeutics
ALDX
$91.7M
$115K ﹤0.01%
34,633
-1,391
-4% -$5.45K
WULF icon
3711
TeraWulf
WULF
$8.44B
$115K ﹤0.01%
25,732
CYRX icon
3712
CryoPort
CYRX
$754M
$114K ﹤0.01%
16,428
-6,760
-29% -$91K
SIGA icon
3713
SIGA Technologies
SIGA
$208M
$113K ﹤0.01%
14,847
+2,727
+23% +$22.2K
CBH
3714
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$113K ﹤0.01%
12,500
-10,000
-44% -$89K
MQ icon
3715
Marqeta
MQ
$1.63B
$112K ﹤0.01%
5,124
-11
-0.2% -$242
SFIX
3716
Stitch Fix
SFIX
$506M
$109K ﹤0.01%
26,205
+700
+3% +$1.9K
JRS icon
3717
Nuveen Real Estate Income Fund
JRS
$243M
$108K ﹤0.01%
14,188
+1,383
+11% +$10.3K
RCS
3718
PIMCO Strategic Income Fund
RCS
$250M
$108K ﹤0.01%
17,335
+1,000
+6% +$5.98K
MDXG icon
3719
MiMedx Group
MDXG
$631M
$106K ﹤0.01%
15,259
+3,005
+25% +$21.1K
LAZR
3720
DELISTED
Luminar Technologies
LAZR
$105K ﹤0.01%
4,688
-72,825
-94% -$1.72M
PR
3721
CALL
Permian Resources
PR
$18B
$103K ﹤0.01%
10,300
PHT
3722
DELISTED
Pioneer High Income Fund
PHT
$103K ﹤0.01%
13,653
-6,496
-32% -$48.3K
PNST
3723
DELISTED
Pinstripes Holdings, Inc.
PNST
$98.5K ﹤0.01%
35,809
ORLA
3724
DELISTED
Orla Mining
ORLA
$97.6K ﹤0.01%
25,416
+1,175
+5% +$4.71K
OPBK icon
3725
OP Bancorp
OPBK
$235M
$96.6K ﹤0.01%
10,078

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.